These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 9888469)
21. Accumulation of analgo of phosphocreatine in muscle of chicks fed 1-carboxymethyl-2-iminoimidazolidine (cyclocreatine). Griffiths GR; Walker JB J Biol Chem; 1976 Apr; 251(7):2049-54. PubMed ID: 1270421 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of creatine analogues as a new class of anticancer agents using freshly explanted human tumor cells. Martin KJ; Chen SF; Clark GM; Degen D; Wajima M; Von Hoff DD; Kaddurah-Daouk R J Natl Cancer Inst; 1994 Apr; 86(8):608-13. PubMed ID: 8145276 [TBL] [Abstract][Full Text] [Related]
23. Liposomal Delivery of Cyclocreatine Impairs Cancer Cell Bioenergetics Mediating Apoptosis. Ganguly S; Elbayoumi T Methods Mol Biol; 2021; 2275():173-186. PubMed ID: 34118038 [TBL] [Abstract][Full Text] [Related]
24. Cerebral metabolism in experimental hydrocephalus: an in vivo 1H and 31P magnetic resonance spectroscopy study. Braun KP; van Eijsden P; Vandertop WP; de Graaf RA; Gooskens RH; Tulleken KA; Nicolay K J Neurosurg; 1999 Oct; 91(4):660-8. PubMed ID: 10507389 [TBL] [Abstract][Full Text] [Related]
25. Cell cycle studies of cyclocreatine, a new anticancer agent. Martin KJ; Winslow ER; Kaddurah-Daouk R Cancer Res; 1994 Oct; 54(19):5160-5. PubMed ID: 7923134 [TBL] [Abstract][Full Text] [Related]
26. Tumor dose response to the vascular disrupting agent, 5,6-dimethylxanthenone-4-acetic acid, using in vivo magnetic resonance spectroscopy. McPhail LD; Chung YL; Madhu B; Clark S; Griffiths JR; Kelland LR; Robinson SP Clin Cancer Res; 2005 May; 11(10):3705-13. PubMed ID: 15897567 [TBL] [Abstract][Full Text] [Related]
27. Use of phosphocreatine kinetics to determine the influence of creatine on muscle mitochondrial respiration: an in vivo 31P-MRS study of oral creatine ingestion. Smith SA; Montain SJ; Zientara GP; Fielding RA J Appl Physiol (1985); 2004 Jun; 96(6):2288-92. PubMed ID: 14978006 [TBL] [Abstract][Full Text] [Related]
28. Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models. Al-Saffar NM; Troy H; Ramírez de Molina A; Jackson LE; Madhu B; Griffiths JR; Leach MO; Workman P; Lacal JC; Judson IR; Chung YL Cancer Res; 2006 Jan; 66(1):427-34. PubMed ID: 16397258 [TBL] [Abstract][Full Text] [Related]
29. Effect of estrogen withdrawal on energy-rich phosphates and prediction of estrogen dependence monitored by in vivo 31P magnetic resonance spectroscopy of four human breast cancer xenografts. Kristensen CA; Kristjansen PE; Brünner N; Clarke R; Spang-Thomsen M; Quistorff B Cancer Res; 1995 Apr; 55(8):1664-9. PubMed ID: 7712472 [TBL] [Abstract][Full Text] [Related]
30. Role of nuclear magnetic resonance spectroscopy (MRS) in cancer diagnosis and treatment: 31P, 23Na, and 1H MRS studies of three models of pancreatic cancer. Kaplan O; Kushnir T; Askenazy N; Knubovets T; Navon G Cancer Res; 1997 Apr; 57(8):1452-9. PubMed ID: 9108445 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and accumulation of an extremely stable high-energy phosphate compound by muscle, heart, and brain of animals fed the creatine analog, 1-carboxyethyl-2-iminoimidazolidine (homocyclocreatine). Roberts JJ; Walker JB Arch Biochem Biophys; 1983 Feb; 220(2):563-71. PubMed ID: 6824340 [TBL] [Abstract][Full Text] [Related]
32. Cerebral creatine kinase deficiency influences metabolite levels and morphology in the mouse brain: a quantitative in vivo 1H and 31P magnetic resonance study. in 't Zandt HJ; Renema WK; Streijger F; Jost C; Klomp DW; Oerlemans F; Van der Zee CE; Wieringa B; Heerschap A J Neurochem; 2004 Sep; 90(6):1321-30. PubMed ID: 15341516 [TBL] [Abstract][Full Text] [Related]
33. Proton magnetic resonance spectroscopy of the brain during acute hypoxia-ischemia and delayed cerebral energy failure in the newborn piglet. Penrice J; Lorek A; Cady EB; Amess PN; Wylezinska M; Cooper CE; D'Souza P; Brown GC; Kirkbride V; Edwards AD; Wyatt JS; Reynolds EO Pediatr Res; 1997 Jun; 41(6):795-802. PubMed ID: 9167191 [TBL] [Abstract][Full Text] [Related]
34. Effect of creatine monohydrate in improving cellular energetics and muscle strength in ambulatory Duchenne muscular dystrophy patients: a randomized, placebo-controlled 31P MRS study. Banerjee B; Sharma U; Balasubramanian K; Kalaivani M; Kalra V; Jagannathan NR Magn Reson Imaging; 2010 Jun; 28(5):698-707. PubMed ID: 20395096 [TBL] [Abstract][Full Text] [Related]
35. In vivo 31P magnetic resonance spectroscopy and 1H magnetic resonance imaging of human bladder carcinoma on nude mice: effects of tumour growth and treatment with cis-dichloro-diamine platinum. De Certaines JD; Albrectsen J; Larsen VA; Xie X; Rygaard J; Henriksen O In Vivo; 1992; 6(6):611-6. PubMed ID: 1296810 [TBL] [Abstract][Full Text] [Related]
36. Phosphorus metabolite distribution in skeletal muscle: quantitative bioenergetics using creatine analogs. Wiseman RW; Kushmerick MJ Mol Cell Biochem; 1997 Sep; 174(1-2):23-8. PubMed ID: 9309661 [TBL] [Abstract][Full Text] [Related]
37. Creatine in the central nervous system: From magnetic resonance spectroscopy to creatine deficiencies. Rackayova V; Cudalbu C; Pouwels PJW; Braissant O Anal Biochem; 2017 Jul; 529():144-157. PubMed ID: 27840053 [TBL] [Abstract][Full Text] [Related]
38. Monitoring tumor growth and regression by 31P magnetic resonance spectroscopy. Stubbs M; Rodrigues LM; Gusterson BA; Griffiths JR Adv Enzyme Regul; 1990; 30():217-30. PubMed ID: 2403032 [TBL] [Abstract][Full Text] [Related]
39. Cyclocreatine in cancer chemotherapy. Teicher BA; Menon K; Northey D; Liu J; Kufe DW; Kaddurah-Daouk R Cancer Chemother Pharmacol; 1995; 35(5):411-6. PubMed ID: 7850923 [TBL] [Abstract][Full Text] [Related]
40. Electrophysiology and biochemical analysis of cyclocreatine uptake and effect in hippocampal slices. Enrico A; Patrizia G; Luisa P; Alessandro P; Gianluigi L; Carlo G; Maurizio B J Integr Neurosci; 2013 Jun; 12(2):285-97. PubMed ID: 23869866 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]